Recon: US cuts $700M in funding for Moderna bird flu vaccine; FDA approves Alcon’s dry eye drug

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States